86 results on '"Nair, Gonasagrie"'
Search Results
52. The Immune Reconstitution Inflammatory Syndrome After Antiretroviral Therapy Initiation in Patients With Tuberculosis: Findings From the SAPiT Trial
53. The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence.
54. Integration of Antiretroviral Therapy with Tuberculosis Treatment
55. Weight Change Among Women Using Intramuscular Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: Findings from a Randomised, Multicentre, Open-Label Trial
56. Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
57. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial
58. Impact of Male Partner Involvement on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial.
59. Impact of an educational video as a consent tool on knowledge about cure research among patients and caregivers at HIV clinics in South Africa
60. HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial
61. Preventive Misconception and Risk Behaviors in a Multinational HIV Prevention Trial.
62. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
63. Age-Disparate Partnerships and Risk of HIV-1 Acquisition Among South African Women Participating in the VOICE Trial
64. Pharmacokinetics and Pharmacodynamics of Tenofovir Reduced-Glycerin 1% Gel in the Rectal and Vaginal Compartments in Women: A Cross-Compartmental Study With Directly Observed Dosing.
65. Immune Reconstitution Inflammatory Syndrome following Antiretroviral Therapy Initiation in Tuberculosis Patients: Findings from the SAPiT Trial
66. Tenofovir-Based Preexposure Prophylaxis for HIV Infection Among African Women
67. Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention
68. Development of a Risk Scoring Tool to Predict HIV-1 Acquisition in African Women
69. Uptake of HBV Vaccination and Incident HBV Infection in Women of Reproductive Age and at Risk of HIV-1 Infection in the VOICE (MTN 003) Study
70. Baseline Characteristics of HIV-1 Negative Women Enrolled into a Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention
71. Prevalent and Incident Gonorrhea and Chlamydia Infections among Oral Contraceptive and Depot Medroxyprogesterone Acetate Users in MTN-003 (VOICE)
72. Age-disparate Partnerships and Risk of HIV-1 Acquisition among South African Women Participating in the VOICE Trial
73. Changes to antiretroviral drug regimens during integrated TB–HIV treatment: results of the SAPiT trial
74. Changes to Antiretroviral Drug Regimens during Integrated TB–HIV Treatment: Results of the Sapit Trial
75. Feasibility, Performance, and Acceptability of the Wisebag™ for Potential Monitoring of Daily Gel Applicator Use in Durban, South Africa
76. Feasibility, Performance, and Acceptability of the Wisebag™ for Potential Monitoring of Daily Gel Applicator Use in Durban, South Africa.
77. Age-disparate Partnerships and Risk of HIV-1 Acquisition among South African Women Participating in the VOICE Trial.
78. Baseline Characteristics of HIV-1 Negative Women Enrolled into a Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention.
79. Uptake of HBV Vaccination and Incident HBV Infection in Women of Reproductive Age and at Risk of HIV-1 Infection in the VOICE (MTN 003) Study.
80. Long-term Follow-up of HIV Seroconverters from the VOICE Trial - An Analysis of Data from MTN-015.
81. Prevalent and Incident Gonorrhea and Chlamydia Infections among Oral Contraceptive and Depot Medroxyprogesterone Acetate Users in MTN-003 (VOICE).
82. Development of a Risk Scoring Tool to Predict HIV-1 Acquisition in African Women.
83. Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.
84. Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial.
85. Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression.
86. Age-Disparate Partnerships and Risk of HIV-1 Acquisition Among South African Women Participating in the VOICE Trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.